Keygene Overview
- Year Founded
-
1989
- Status
-
Private
- Employees
-
135
- Latest Deal Type
-
Corporate
- Financing Rounds
-
1
- Investments
-
1
Keygene General Information
Description
Operator of an AgBiotech company focused to work for the future of global agriculture with partners in the AgriFood sector. The company specializes in crop improvement by molecular breeding and non-GM approaches, thereby supporting customers with R&D challenges along with the development of new and improved crops.
Contact Information
Website
www.keygene.comCorporate Office
- Post Office Box 216
- 6700 AE Wageningen
- Netherlands
Corporate Office
- Post Office Box 216
- 6700 AE Wageningen
- Netherlands
Keygene Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Keygene Comparisons
Industry
Financing
Details
Keygene Competitors (3)
One of Keygene’s 3 competitors is Novonesis, a Corporation company based in Lyngby, Denmark.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Novonesis | Corporation | Lyngby, Denmark | ||||
| PlantArcBio | Formerly Angel backed | Givat Chen, Israel | ||||
| Syngenta | Formerly Accelerator/Incubator backed | Basel, Switzerland |
Keygene Patents
Keygene Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026132093-A1 | Intergrafting tool and method of generating an intergraft using the same | Pending | 20-Dec-2024 | ||
| WO-2026115077-A1 | Improved protocol for random mutagenesis | Pending | 28-Nov-2024 | ||
| WO-2025257212-A1 | Screening and regeneration of protoplast callus | Pending | 11-Jun-2024 | ||
| EP-4795210-A1 | Selection of specific genotypes in cells using a craspase complex | Pending | 16-Oct-2023 | ||
| WO-2025083000-A1 | Selection of specific genotypes in cells using a craspase complex | Inactive | 16-Oct-2023 | C12N9/22 |
Keygene Signals
Keygene Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Keygene Investments (1)
Keygene’s most recent deal was a Joint Venture with Yelloway. The deal was made on 01-Jan-2020.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Yelloway | 01-Jan-2020 | Joint Venture | Cultivation |
Keygene FAQs
-
When was Keygene founded?
Keygene was founded in 1989.
-
Where is Keygene headquartered?
Keygene is headquartered in Wageningen, Netherlands.
-
What is the size of Keygene?
Keygene has 135 total employees.
-
What industry is Keygene in?
Keygene’s primary industry is Cultivation.
-
Is Keygene a private or public company?
Keygene is a Private company.
-
What is Keygene’s current revenue?
The current revenue for Keygene is .
-
Who are Keygene’s investors?
Vilmorin & Cie has invested in Keygene.
-
Who are Keygene’s competitors?
Novonesis, PlantArcBio, and Syngenta are competitors of Keygene.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process